Kevin J. Clerkin

ABO Blood Group Mismatch in Heart Transplantation Is Not Associated With Elevated Donor-Derived Cell-Free DNA

Donor-derived cell-free DNA (dd-cfDNA) is a reliable, noninvasive marker for detecting allograft rejection after heart transplantation (HT). We evaluated whether dd-cfDNA levels differ in recipients of ABO-compatible, nonidentical (mismatched) grafts. We performed a retrospective...